Cubist Systematic Strategies’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Cubist Systematic Strategies’s Portfolio PRDS Stock Details PRDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-13,120	Closed	-$23.7K	–	4190
2023 Q2	$23.7K	Buy	+13,120	New	+$24K	﹤0.01%	3166
2022 Q3	–	Sell	-7,800	Closed	-$24K	–	4906
2022 Q2	$24K	Sell	7,800 -38,500	-83%	-$235K	﹤0.01%	4194
2022 Q1	$334K	Buy	46,300 +44,094	+1,999%	+$434K	﹤0.01%	2779
2021 Q4	$36K	Buy	+2,206	New	+$25.7K	﹤0.01%	3343

Other funds holding PRDS

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Cubist Systematic Strategies's PRDS Position: Q3 2023 in Review

Cubist Systematic Strategies sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q3 2023, closing a stake of 13,120 shares — an estimated $23.7K sold.

Cubist Systematic Strategies first reported a position in PRDS in Q4 2021 and held it in 4 quarters. The position peaked at $334K in Q1 2022. 1 fund tracked by Wall St. Rank holds PRDS as of Q3 2023.

Cubist Systematic Strategies reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Cubist Systematic Strategies sold 13,120 Pardes Biosciences, Inc. Common Stock shares in Q3 2023, an estimated $23.7K.
Cubist Systematic Strategies first reported a position in Pardes Biosciences, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
Cubist Systematic Strategies's Pardes Biosciences, Inc. Common Stock position peaked at $334K in Q1 2022.
1 fund tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q3 2023.

Based on Cubist Systematic Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.